Effect of propolis as an adjuvant treatment of Helicobacter pylori
Phase 3
Recruiting
- Conditions
- Helicobacter Pylori infection.
- Registration Number
- IRCT20230503058065N1
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with symptoms of dyspepsia
Helicobacter pylori patients with a positive biopsy test
Exclusion Criteria
People with duodenal gastrointestinal bleeding
Pregnant women
Breastfeeding women
Patients with liver disorders
Patients with renal failure
Patients with heart failure
Patients with a history of drug sensitivity to any of the studied drugs
Patients who have previously been treated with Helicobacter pylori therapy
Patients taking NSAIDs
Patients who are taking corticosteroids
Patients with a history of alcohol consumption
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of digestive symptoms. Timepoint: 60 days after the start of the intervention. Method of measurement: Questionnaire and fecal antigen test.
- Secondary Outcome Measures
Name Time Method Helicobacter pylori eradication. Timepoint: 60 days after the start of the intervention. Method of measurement: Fecal antigen test.